Randomized-controlled trial evaluating the outcome between switching to tenofovir disoproxil fumarate(TDF)/lamivudine(3TC)/dolutegravir(DTG)
versus maintaining the current NNRTI or boosted-PI-containing regimen in PLWH in Thailand - a pilot study from single center
